Teresa Petrella, University of Windsor

Research

Barriers To Clinical Trials Clinical Trials Acrrual Equity Of Access Implementation Science Oncology Pragmatic Wedge-Step Cluster Randomization

Latest papers

Biochemotherapy for the treatment of metastatic malignant melanoma: a systematic review.
Cancer treatment reviews · 2008

All 1 publications

Latest funding

Enhancing the Patient Journey to Clinical Trial Enrolment with Navigation to Optimize Accrual: A Pilot Study for a pragmatic multi-centre, stepped wedge, cluster randomized controlled trial (The CTN Pilot Trial)
CIHR · 2023 · Principal investigator
$198,825
A Population Study of the Toxicity and Effectiveness of High-Dose Interferon for High-Risk Melanoma
CIHR · 2014 · Co-investigator
$360,993

All 2 grants and awards

1 publications.

01

Biochemotherapy for the treatment of metastatic malignant melanoma: a systematic review.

Hamm C, Verma S, Petrella T, Bak K, Charette M, Melanoma Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care

Cancer treatment reviews2008

DOI: 10.1016/j.ctrv.2007.10.003 PMID: 18077098

Enhancing the Patient Journey to Clinical Trial Enrolment with Navigation to Optimize Accrual: A Pilot Study for a pragmatic multi-centre, stepped wedge, cluster randomized controlled trial (The CTN Pilot Trial)

Principal investigatorCIHR2023Catalyst Grant: SPOR Innovative Clinical Trials (iCT)

Principal investigators: Hamm, Caroline; Delisle, Megan; Laferriere, Nicole; Marley, Diane J; Perera, Sheron N; Petrella, Teresa M

Keywords: Barriers To Clinical Trials; Clinical Trials Acrrual; Equity Of Access; Implementation Science; Oncology; Pragmatic; Wedge-Step Cluster Randomization

$198,825

A Population Study of the Toxicity and Effectiveness of High-Dose Interferon for High-Risk Melanoma

Co-investigatorCIHR2014Operating Grant

Principal investigators: Hanna, Timothy P

Keywords: Drug Therapy; Effectiveness; Health Services Research; Interferon (High-Dose); Melanoma; Population-Level Study; Quality; Safety; Survival; Toxicity

$360,993

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Caroline Hamm

Faculty

1 shared papers, latest 2008

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2023

Subject: Prospective PhD student: Barriers To Clinical Trials Dear Professor Petrella, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Biochemotherapy for the treatment of metastatic malignant melanoma: a systematic review." (2008), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Enhancing the Patient Journey to Clinical Trial Enrolment with Navigation to Optimize Accrual: A Pilot Study for a pragmatic multi-centre, stepped wedge, cluster randomized controlled trial (The CTN Pilot Trial)" (2023), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]